clinical nephrology

You have accessRestricted Access
Symptomatic and Radiographic Manifestations of Kidney Stone Recurrence and Their Prediction by Risk Factors: A Prospective Cohort Study
Matthew R. D’Costa, William E. Haley, Kristin C. Mara, Felicity T. Enders, Terri J. Vrtiska, Vernon M. Pais, Steven J. Jacobsen, Cynthia H. McCollough, John C. Lieske and Andrew D. Rule

JASN July 2019, 30 (7) 1251-1260; DOI: https://doi.org/10.1681/ASN.2018121241

Add to Selected Citations
You have accessRestricted Access
An Organizational-Level Program of Intervention for AKI: A Pragmatic Stepped Wedge Cluster Randomized Trial
Nicholas M. Selby, Anna Casula, Laura Lamming, John Stoves, Yohan Samarasinghe, Andrew J. Lewington, Russell Roberts, Nikunj Shah, Melanie Johnson, Natalie Jackson, Carol Jones, Erik Lenguerrand, Eileen McDonach, Richard J. Fluck, Mohammed A. Mohammed and Fergus J. Caskey

JASN March 2019, 30 (3) 505-515; DOI: https://doi.org/10.1681/ASN.2018090886

Add to Selected Citations
Open Access
Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss
Stephen Zewinger, Thomas Rauen, Michael Rudnicki, Giuseppina Federico, Martina Wagner, Sarah Triem, Stefan J. Schunk, Ioannis Petrakis, David Schmit, Stefan Wagenpfeil, Gunnar H. Heine, Gert Mayer, Jürgen Floege, Danilo Fliser, Hermann-Josef Gröne and Thimoteus Speer

JASN November 2018, 29 (11) 2722-2733; DOI: https://doi.org/10.1681/ASN.2018040405

Add to Selected Citations
You have accessRestricted Access
Should Statins Be Banned from Dialysis?
An S. De Vriese

JASN June 2017, 28 (6) 1675-1676; DOI: https://doi.org/10.1681/ASN.2017020201

Add to Selected Citations
You have accessRestricted Access
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness
David E. Leaf, Kirolos A. Jacob, Anand Srivastava, Margaret E. Chen, Marta Christov, Harald Jüppner, Venkata S. Sabbisetti, Aline Martin, Myles Wolf and Sushrut S. Waikar

JASN June 2017, 28 (6) 1877-1885; DOI: https://doi.org/10.1681/ASN.2016080836

Add to Selected Citations
You have accessRestricted Access
Membranous Nephropathy: Quantifying Remission Duration on Outcome
Daniel C. Cattran, Esther D. Kim, Heather Reich, Michelle Hladunewich, S. Joseph Kim and for the Toronto Glomerulonephritis Registry group

JASN March 2017, 28 (3) 995-1003; DOI: https://doi.org/10.1681/ASN.2015111262

Add to Selected Citations
You have accessRestricted Access
A Proposal for a Serology-Based Approach to Membranous Nephropathy
An S. De Vriese, Richard J. Glassock, Karl A. Nath, Sanjeev Sethi and Fernando C. Fervenza

JASN February 2017, 28 (2) 421-430; DOI: https://doi.org/10.1681/ASN.2016070776

Add to Selected Citations
You have accessRestricted Access
Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy
Hua-Zhang Qin, Ming-Chao Zhang, Wei-Bo Le, Qiang Ren, Da-Cheng Chen, Cai-Hong Zeng, Lei Liu, Ke Zuo, Feng Xu and Zhi-Hong Liu

JASN October 2016, 27 (10) 3195-3203; DOI: https://doi.org/10.1681/ASN.2015080953

Add to Selected Citations
Open Access
Glycosylation Profile of IgG in Moderate Kidney Dysfunction
Clara Barrios, Jonas Zierer, Ivan Gudelj, Jerko Štambuk, Ivo Ugrina, Eva Rodríguez, María José Soler, Tamara Pavić, Mirna Šimurina, Toma Keser, Maja Pučić-Baković, Massimo Mangino, Julio Pascual, Tim D Spector, Gordan Lauc and Cristina Menni

JASN March 2016, 27 (3) 933-941; DOI: https://doi.org/10.1681/ASN.2015010109

Add to Selected Citations
You have accessRestricted Access
Hepatocyte Nuclear Factor 1β–Associated Kidney Disease: More than Renal Cysts and Diabetes
Jacobien C. Verhave, Anneke P. Bech, Jack F.M. Wetzels and Tom Nijenhuis

JASN February 2016, 27 (2) 345-353; DOI: https://doi.org/10.1681/ASN.2015050544

Add to Selected Citations

Main menu

User menu

Search

clinical nephrology

Pages

About

Author Information

More Information